Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

NCT02475681 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

535

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Acalabrutinib
DRUG: Obinutuzumab
DRUG: Chlorambucil

Sponsor

Acerta Pharma BV